These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38310878)

  • 1. Glycemic Control Is Associated with Histological Findings of Nonalcoholic Fatty Liver Disease.
    Miyake T; Furukawa S; Matsuura B; Yoshida O; Miyazaki M; Shiomi A; Kanamoto A; Nakaguchi H; Nakamura Y; Imai Y; Koizumi M; Watanabe T; Yamamoto Y; Koizumi Y; Tokumoto Y; Hirooka M; Kumagi T; Takesita E; Ikeda Y; Abe M; Hiasa Y
    Diabetes Metab J; 2024 May; 48(3):440-448. PubMed ID: 38310878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycemic Control Predicts Severity of Hepatocyte Ballooning and Hepatic Fibrosis in Nonalcoholic Fatty Liver Disease.
    Alexopoulos AS; Crowley MJ; Wang Y; Moylan CA; Guy CD; Henao R; Piercy DL; Seymour KA; Sudan R; Portenier DD; Diehl AM; Coviello AD; Abdelmalek MF
    Hepatology; 2021 Sep; 74(3):1220-1233. PubMed ID: 33724511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IMPACT OF TYPE 2 DIABETES ON NONALCOHOLIC STEATOHEPATITIS AND ADVANCED FIBROSIS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE.
    Bian H; Zhu X; Xia M; Yan H; Chang X; Hu X; Pan B; Guo W; Li X; Gao X
    Endocr Pract; 2020 Apr; 26(4):444-453. PubMed ID: 31968197
    [No Abstract]   [Full Text] [Related]  

  • 4. Association of glycated hemoglobin with the risk of advanced fibrosis in non-alcoholic fatty liver disease patients without diabetes.
    Yu C; Wang L; Xue H; Lin H; Li Y; Chan SO
    Clin Res Hepatol Gastroenterol; 2019 Feb; 43(1):58-66. PubMed ID: 30274911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased risks of different grades of non-alcoholic fatty liver disease in prediabetic subjects with impaired fasting glucose and glucose tolerance, including the isolated glycosylated hemoglobin levels of 5.7-6.4% in a Chinese population.
    Li CH; Chou YT; Shen WC; Lu FH; Yang YC; Wu JS; Chang CJ
    J Diabetes Investig; 2020 Sep; 11(5):1336-1343. PubMed ID: 32270583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for histological progression of non-alcoholic steatohepatitis analyzed from repeated biopsy cases.
    Daijo K; Nakahara T; Inagaki Y; Nanba M; Nishida Y; Uchikawa S; Kodama K; Oya K; Morio K; Fujino H; Ono A; Murakami E; Yamauchi M; Kawaoka T; Miki D; Tsuge M; Hiramatsu A; Hayes CN; Imamura M; Aikata H; Ochi H; Chayama K
    J Gastroenterol Hepatol; 2020 Aug; 35(8):1412-1419. PubMed ID: 31896166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-alcoholic fatty liver disease - histological scoring systems: a large cohort single-center, evaluation study.
    Rastogi A; Shasthry SM; Agarwal A; Bihari C; Jain P; Jindal A; Sarin S
    APMIS; 2017 Nov; 125(11):962-973. PubMed ID: 29076589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycemic variability is an independent predictive factor for development of hepatic fibrosis in nonalcoholic fatty liver disease.
    Hashiba M; Ono M; Hyogo H; Ikeda Y; Masuda K; Yoshioka R; Ishikawa Y; Nagata Y; Munekage K; Ochi T; Hirose A; Nozaki-Fujimura Y; Noguchi S; Okamoto N; Chayama K; Suganuma N; Saibara T
    PLoS One; 2013; 8(11):e76161. PubMed ID: 24223115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histologic Findings of Advanced Fibrosis and Cirrhosis in Patients With Nonalcoholic Fatty Liver Disease Who Have Normal Aminotransferase Levels.
    Gawrieh S; Wilson LA; Cummings OW; Clark JM; Loomba R; Hameed B; Abdelmalek MF; Dasarathy S; Neuschwander-Tetri BA; Kowdley K; Kleiner D; Doo E; Tonascia J; Sanyal A; Chalasani N;
    Am J Gastroenterol; 2019 Oct; 114(10):1626-1635. PubMed ID: 31517638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of nonalcoholic fatty liver disease and liver cirrhosis in Chinese adults with type 2 diabetes mellitus.
    Han X; Zhang X; Liu Z; Fan H; Guo C; Wang H; Gu Y; Zhang T
    J Diabetes; 2024 May; 16(5):e13564. PubMed ID: 38664879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical validation of the FLIP algorithm and the SAF score in patients with non-alcoholic fatty liver disease.
    Nascimbeni F; Bedossa P; Fedchuk L; Pais R; Charlotte F; Lebray P; Poynard T; Ratziu V;
    J Hepatol; 2020 May; 72(5):828-838. PubMed ID: 31862486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced fibrosis of non-alcoholic steatohepatitis affects the significance of lipoprotein(a) as a cardiovascular risk factor.
    Konishi K; Miyake T; Furukawa S; Senba H; Kanzaki S; Nakaguchi H; Yukimoto A; Nakamura Y; Watanabe T; Koizumi Y; Yoshida O; Tokumoto Y; Hirooka M; Kumagi T; Abe M; Matsuura B; Hiasa Y
    Atherosclerosis; 2020 Apr; 299():32-37. PubMed ID: 32203743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sitagliptin in patients with non-alcoholic steatohepatitis: A randomized, placebo-controlled trial.
    Joy TR; McKenzie CA; Tirona RG; Summers K; Seney S; Chakrabarti S; Malhotra N; Beaton MD
    World J Gastroenterol; 2017 Jan; 23(1):141-150. PubMed ID: 28104990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of lean patients with nonalcoholic fatty liver disease: potential role of high hemoglobin levels.
    Akyuz U; Yesil A; Yilmaz Y
    Scand J Gastroenterol; 2015 Mar; 50(3):341-6. PubMed ID: 25540973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Association between glycosylated hemoglobin and 
non-alcoholic fatty liver disease in 
health examination population].
    Zhang Q; Yu Y; Yang M; Lin X; Liu Y; Xu X
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 May; 42(5):529-535. PubMed ID: 28626098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying Nonalcoholic Fatty Liver Disease Advanced Fibrosis in the Veterans Health Administration.
    Patel YA; Gifford EJ; Glass LM; Turner MJ; Han B; Moylan CA; Choi S; Suzuki A; Provenzale D; Hunt CM
    Dig Dis Sci; 2018 Sep; 63(9):2259-2266. PubMed ID: 29779083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of grade of non-alcoholic fatty liver disease and glycated albumin to glycated hemoglobin ratio in patients with type 2 diabetes mellitus.
    Jung CH; Lee B; Choi DH; Jung SH; Kim BY; Kim CH; Kang SK; Mok JO
    Diabetes Res Clin Pract; 2017 Mar; 125():53-61. PubMed ID: 28167326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Predictive value of serum glycosylated hemoglobin for the onset of nonalcoholic fatty liver disease].
    Chen CX; Du J; Xu YM; Han JX; Zhu ZW; Mao YS; Guo CY
    Zhonghua Gan Zang Bing Za Zhi; 2018 Oct; 26(10):765-770. PubMed ID: 30481883
    [No Abstract]   [Full Text] [Related]  

  • 19. Ultrasonographic Nonalcoholic Fatty Pancreas Is Associated with Advanced Fibrosis in NAFLD: A Retrospective Analysis.
    Rosenblatt R; Mehta A; Snell D; Hissong E; Kierans AS; Kumar S
    Dig Dis Sci; 2019 Jan; 64(1):262-268. PubMed ID: 30269271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycemic Measures and Development and Resolution of Nonalcoholic Fatty Liver Disease in Nondiabetic Individuals.
    Wang B; Li M; Zhao Z; Wang S; Lu J; Chen Y; Xu M; Wang W; Ning G; Bi Y; Wang T; Xu Y
    J Clin Endocrinol Metab; 2020 May; 105(5):. PubMed ID: 32144419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.